Reckitt Benckiser to demerge pharmaceutical unit

Reckitt Benckiser (OTCPK:RBGLY) states that it will pursue a demerger of its pharmaceutical division, allowing it to put a greater focus on its core consumer health and hygiene business.

The spinoff will occur in the next 12 months - becoming a separate U.K.-listed company.

The announcement follows the Reckitt Benckiser's 7% drop in second-quarter revenue which fell to £2.3B from £2.5B Y/Y.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs